SAP and MAP patients in this study were presented the similar co‐morbidities, such as cholecystitis, hypertension, diabetes, cholelithiasis and hyperlipemia etc. Our data showed that Card9 in the SAP group were significantly higher than that in the MAP, indicating its specificity in relation to pancreatitis. This evidence concerns the gene CARD9 and familial hyperlipidemia.